SPORTS Young blood spearhead Jilin victory at CBA's reopner


Young blood spearhead Jilin victory at CBA's reopner

By Li Xiang | CGTN

16:40, June 21, 2020

Jiang Yuxing (C) of the Jilin Northeastern Tigers makes a layup against the Sichuan Blue Whales in Dongguan, south China's Guangdong Province, June 21, 2020.

In the first game of the restarted CBA competion on Sunday, Jilin Northeastern Tigers beat the Sichuan Blue Whales 97-85 in Dongguan, south China's Guangdong Province.

The victory marked Jilin's second over Sichuan this season, which had been suspended for nearly five months because of the coronavirus outbreak.

Sichuan's half-court defense helped send their team to a 10-2 lead at one stage in the first quarter by making Jilin very uncomfortable in the early exchanges. Their big man Li Yuanyu made a shot from downtown to score the first point for Sichuan and he was also the best-performing player of the team. Li went 10-15 to drop 31 points, 10 rebounds and two blocks. Jilin invested tremendous effort in trying to limit him – the three players defending Li committed a total of 11 fouls – but they just could not stop him.

However, Li alone was not able to carry the whole team. Three of Jilin's young players, Jiang Yuxing, Cui Jinming and Dai Huaibo put down 23, 15 and 25 points for their team. As the first selectee of the 2018 CBA Draft, Jiang led Jilin in coming back by scoring 15 points in the second quarter. Thanks to his explosive performance, Jilin reversed the situation with a 24-9 run.

Scheduled games on Sunday:

Zhejiang Golden Bulls vs. Shanghai Sharks

Shandong Heroes vs. Tianjian Pioneers

Guangzhou Loong Lions vs. Bayi Rockets

Beijing Royal Fighters vs. Fujian Sturgeons

Terms of Service & Privacy Policy

We have updated our privacy policy to comply with the latest laws and regulations. The updated policy explains the mechanism of how we collect and treat your personal data. You can learn more about the rights you have by reading our terms of service. Please read them carefully. By clicking AGREE, you indicate that you have read and agreed to our privacy policies

Agree and continue